nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP2A6—esophageal cancer	0.411	0.566	CbGaD
Rosiglitazone—PTGS1—esophageal cancer	0.315	0.434	CbGaD
Rosiglitazone—SLCO1B1—Methotrexate—esophageal cancer	0.0358	0.344	CbGbCtD
Rosiglitazone—CYP2C9—Capecitabine—esophageal cancer	0.0323	0.311	CbGbCtD
Rosiglitazone—ALB—Methotrexate—esophageal cancer	0.0196	0.189	CbGbCtD
Rosiglitazone—CYP2C9—Cisplatin—esophageal cancer	0.0163	0.157	CbGbCtD
Rosiglitazone—Pioglitazone—PTGS1—esophageal cancer	0.00199	1	CrCbGaD
Rosiglitazone—ACSL4—bronchus—esophageal cancer	0.00138	0.108	CbGeAlD
Rosiglitazone—ACSL4—trachea—esophageal cancer	0.00124	0.0971	CbGeAlD
Rosiglitazone—Haematocrit decreased—Methotrexate—esophageal cancer	0.00107	0.0307	CcSEcCtD
Rosiglitazone—ACSL4—digestive system—esophageal cancer	0.00107	0.0836	CbGeAlD
Rosiglitazone—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.000933	0.0267	CcSEcCtD
Rosiglitazone—PPARG—neck—esophageal cancer	0.000929	0.0726	CbGeAlD
Rosiglitazone—Visual acuity reduced—Capecitabine—esophageal cancer	0.000901	0.0258	CcSEcCtD
Rosiglitazone—ACSL4—lung—esophageal cancer	0.000892	0.0698	CbGeAlD
Rosiglitazone—Infection—Carboplatin—esophageal cancer	0.000879	0.0252	CcSEcCtD
Rosiglitazone—Blood triglycerides increased—Capecitabine—esophageal cancer	0.000818	0.0234	CcSEcCtD
Rosiglitazone—Pleural effusion—Capecitabine—esophageal cancer	0.0007	0.02	CcSEcCtD
Rosiglitazone—Fluid retention—Cisplatin—esophageal cancer	0.00069	0.0198	CcSEcCtD
Rosiglitazone—Fracture—Methotrexate—esophageal cancer	0.000687	0.0197	CcSEcCtD
Rosiglitazone—Multiple fractures—Methotrexate—esophageal cancer	0.000687	0.0197	CcSEcCtD
Rosiglitazone—Myocardial ischaemia—Capecitabine—esophageal cancer	0.000667	0.0191	CcSEcCtD
Rosiglitazone—PPARG—epithelium—esophageal cancer	0.000632	0.0494	CbGeAlD
Rosiglitazone—ACSL4—lymph node—esophageal cancer	0.00061	0.0477	CbGeAlD
Rosiglitazone—PPARG—smooth muscle tissue—esophageal cancer	0.000609	0.0476	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000589	0.0169	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000582	0.0167	CcSEcCtD
Rosiglitazone—SLCO1B1—digestive system—esophageal cancer	0.000557	0.0436	CbGeAlD
Rosiglitazone—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000539	0.0154	CcSEcCtD
Rosiglitazone—Pleural effusion—Methotrexate—esophageal cancer	0.000521	0.0149	CcSEcCtD
Rosiglitazone—Fluid retention—Capecitabine—esophageal cancer	0.000509	0.0146	CcSEcCtD
Rosiglitazone—PPARG—digestive system—esophageal cancer	0.000481	0.0376	CbGeAlD
Rosiglitazone—Nasopharyngitis—Cisplatin—esophageal cancer	0.000472	0.0135	CcSEcCtD
Rosiglitazone—CYP2A6—lung—esophageal cancer	0.000472	0.0369	CbGeAlD
Rosiglitazone—Diabetes mellitus—Capecitabine—esophageal cancer	0.000447	0.0128	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000445	0.0127	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000439	0.0126	CcSEcCtD
Rosiglitazone—Hepatic failure—Capecitabine—esophageal cancer	0.000433	0.0124	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000422	0.0121	CcSEcCtD
Rosiglitazone—Increased appetite—Capecitabine—esophageal cancer	0.000414	0.0119	CcSEcCtD
Rosiglitazone—PPARG—lung—esophageal cancer	0.000401	0.0314	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000401	0.0115	CcSEcCtD
Rosiglitazone—Myocardial infarction—Cisplatin—esophageal cancer	0.000399	0.0114	CcSEcCtD
Rosiglitazone—Cardiac failure—Capecitabine—esophageal cancer	0.000399	0.0114	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000397	0.0114	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000385	0.011	CcSEcCtD
Rosiglitazone—CYP2C19—digestive system—esophageal cancer	0.000363	0.0284	CbGeAlD
Rosiglitazone—Connective tissue disorder—Cisplatin—esophageal cancer	0.000359	0.0103	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Methotrexate—esophageal cancer	0.000355	0.0102	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Capecitabine—esophageal cancer	0.000348	0.00996	CcSEcCtD
Rosiglitazone—Eye disorder—Cisplatin—esophageal cancer	0.000341	0.00977	CcSEcCtD
Rosiglitazone—Cardiac disorder—Cisplatin—esophageal cancer	0.000339	0.0097	CcSEcCtD
Rosiglitazone—PTGS1—epithelium—esophageal cancer	0.000338	0.0264	CbGeAlD
Rosiglitazone—Diabetes mellitus—Methotrexate—esophageal cancer	0.000333	0.00953	CcSEcCtD
Rosiglitazone—Immune system disorder—Cisplatin—esophageal cancer	0.00033	0.00944	CcSEcCtD
Rosiglitazone—PTGS1—smooth muscle tissue—esophageal cancer	0.000326	0.0255	CbGeAlD
Rosiglitazone—Hepatic failure—Methotrexate—esophageal cancer	0.000322	0.00923	CcSEcCtD
Rosiglitazone—Malnutrition—Cisplatin—esophageal cancer	0.000318	0.0091	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000313	0.00895	CcSEcCtD
Rosiglitazone—Weight increased—Capecitabine—esophageal cancer	0.000306	0.00876	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Capecitabine—esophageal cancer	0.000303	0.00868	CcSEcCtD
Rosiglitazone—PTGS1—trachea—esophageal cancer	0.000299	0.0234	CbGeAlD
Rosiglitazone—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000297	0.00851	CcSEcCtD
Rosiglitazone—CYP1A2—digestive system—esophageal cancer	0.000297	0.0232	CbGeAlD
Rosiglitazone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000296	0.00846	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000296	0.00846	CcSEcCtD
Rosiglitazone—Myocardial infarction—Capecitabine—esophageal cancer	0.000294	0.00841	CcSEcCtD
Rosiglitazone—Anaemia—Cisplatin—esophageal cancer	0.000294	0.00841	CcSEcCtD
Rosiglitazone—Leukopenia—Cisplatin—esophageal cancer	0.000285	0.00815	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000284	0.00812	CcSEcCtD
Rosiglitazone—CYP2C9—digestive system—esophageal cancer	0.000282	0.022	CbGeAlD
Rosiglitazone—PPARG—lymph node—esophageal cancer	0.000275	0.0215	CbGeAlD
Rosiglitazone—Myalgia—Cisplatin—esophageal cancer	0.000271	0.00775	CcSEcCtD
Rosiglitazone—Hepatitis—Capecitabine—esophageal cancer	0.000269	0.00771	CcSEcCtD
Rosiglitazone—Oedema peripheral—Capecitabine—esophageal cancer	0.000265	0.00759	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Capecitabine—esophageal cancer	0.000264	0.00757	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000259	0.00743	CcSEcCtD
Rosiglitazone—Oedema—Cisplatin—esophageal cancer	0.000259	0.00743	CcSEcCtD
Rosiglitazone—Infection—Cisplatin—esophageal cancer	0.000258	0.00738	CcSEcCtD
Rosiglitazone—ALB—lymph node—esophageal cancer	0.000258	0.0201	CbGeAlD
Rosiglitazone—PTGS1—digestive system—esophageal cancer	0.000257	0.0201	CbGeAlD
Rosiglitazone—Erythema multiforme—Capecitabine—esophageal cancer	0.000254	0.00729	CcSEcCtD
Rosiglitazone—Nervous system disorder—Cisplatin—esophageal cancer	0.000254	0.00728	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Cisplatin—esophageal cancer	0.000254	0.00727	CcSEcCtD
Rosiglitazone—Eye disorder—Capecitabine—esophageal cancer	0.000252	0.0072	CcSEcCtD
Rosiglitazone—Cardiac disorder—Capecitabine—esophageal cancer	0.00025	0.00715	CcSEcCtD
Rosiglitazone—CYP1A2—lung—esophageal cancer	0.000248	0.0194	CbGeAlD
Rosiglitazone—Immune system disorder—Capecitabine—esophageal cancer	0.000243	0.00696	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000236	0.00677	CcSEcCtD
Rosiglitazone—Malnutrition—Capecitabine—esophageal cancer	0.000234	0.00671	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000233	0.00666	CcSEcCtD
Rosiglitazone—Back pain—Capecitabine—esophageal cancer	0.000227	0.00649	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000224	0.00641	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000221	0.00634	CcSEcCtD
Rosiglitazone—Anaemia—Capecitabine—esophageal cancer	0.000217	0.0062	CcSEcCtD
Rosiglitazone—PTGS1—lung—esophageal cancer	0.000215	0.0168	CbGeAlD
Rosiglitazone—CYP2D6—digestive system—esophageal cancer	0.000211	0.0165	CbGeAlD
Rosiglitazone—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000211	0.00604	CcSEcCtD
Rosiglitazone—Leukopenia—Capecitabine—esophageal cancer	0.00021	0.006	CcSEcCtD
Rosiglitazone—Hypertension—Capecitabine—esophageal cancer	0.000202	0.00579	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—esophageal cancer	0.0002	0.00574	CcSEcCtD
Rosiglitazone—Arthralgia—Capecitabine—esophageal cancer	0.000199	0.00571	CcSEcCtD
Rosiglitazone—Myalgia—Capecitabine—esophageal cancer	0.000199	0.00571	CcSEcCtD
Rosiglitazone—Oedema—Capecitabine—esophageal cancer	0.000191	0.00547	CcSEcCtD
Rosiglitazone—Infection—Capecitabine—esophageal cancer	0.00019	0.00544	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—esophageal cancer	0.000189	0.00542	CcSEcCtD
Rosiglitazone—Nervous system disorder—Capecitabine—esophageal cancer	0.000188	0.00537	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—esophageal cancer	0.000187	0.00536	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Capecitabine—esophageal cancer	0.000187	0.00536	CcSEcCtD
Rosiglitazone—Asthenia—Cisplatin—esophageal cancer	0.000186	0.00533	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—esophageal cancer	0.000186	0.00532	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—esophageal cancer	0.000181	0.00518	CcSEcCtD
Rosiglitazone—Diarrhoea—Cisplatin—esophageal cancer	0.000177	0.00508	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—esophageal cancer	0.000174	0.00499	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000174	0.00499	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—esophageal cancer	0.000169	0.00483	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000165	0.00473	CcSEcCtD
Rosiglitazone—Fatigue—Capecitabine—esophageal cancer	0.000165	0.00472	CcSEcCtD
Rosiglitazone—Rash—Cisplatin—esophageal cancer	0.000164	0.00468	CcSEcCtD
Rosiglitazone—Constipation—Capecitabine—esophageal cancer	0.000164	0.00468	CcSEcCtD
Rosiglitazone—Dermatitis—Cisplatin—esophageal cancer	0.000163	0.00468	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—esophageal cancer	0.000161	0.00462	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—esophageal cancer	0.000156	0.00447	CcSEcCtD
Rosiglitazone—Nausea—Cisplatin—esophageal cancer	0.000154	0.00441	CcSEcCtD
Rosiglitazone—Urticaria—Capecitabine—esophageal cancer	0.000152	0.00435	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—esophageal cancer	0.000148	0.00425	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—esophageal cancer	0.000148	0.00425	CcSEcCtD
Rosiglitazone—PTGS1—lymph node—esophageal cancer	0.000147	0.0115	CbGeAlD
Rosiglitazone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000142	0.00408	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—esophageal cancer	0.000141	0.00405	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—esophageal cancer	0.00014	0.004	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—esophageal cancer	0.000139	0.00399	CcSEcCtD
Rosiglitazone—Asthenia—Capecitabine—esophageal cancer	0.000137	0.00393	CcSEcCtD
Rosiglitazone—Pruritus—Capecitabine—esophageal cancer	0.000135	0.00387	CcSEcCtD
Rosiglitazone—Diarrhoea—Capecitabine—esophageal cancer	0.000131	0.00375	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00013	0.00371	CcSEcCtD
Rosiglitazone—Dizziness—Capecitabine—esophageal cancer	0.000126	0.00362	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000123	0.00352	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—esophageal cancer	0.000123	0.00351	CcSEcCtD
Rosiglitazone—Rash—Capecitabine—esophageal cancer	0.000121	0.00345	CcSEcCtD
Rosiglitazone—Dermatitis—Capecitabine—esophageal cancer	0.00012	0.00345	CcSEcCtD
Rosiglitazone—Headache—Capecitabine—esophageal cancer	0.00012	0.00343	CcSEcCtD
Rosiglitazone—Nausea—Capecitabine—esophageal cancer	0.000114	0.00325	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—esophageal cancer	0.000113	0.00324	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—esophageal cancer	0.000102	0.00292	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—esophageal cancer	0.000101	0.00288	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—esophageal cancer	9.74e-05	0.00279	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—esophageal cancer	9.41e-05	0.0027	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—esophageal cancer	8.98e-05	0.00257	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—esophageal cancer	8.97e-05	0.00257	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—esophageal cancer	8.92e-05	0.00255	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—esophageal cancer	8.46e-05	0.00242	CcSEcCtD
Rosiglitazone—CYP2A6—Metabolism—GSTT1—esophageal cancer	2.08e-05	0.000172	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.08e-05	0.000172	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.07e-05	0.000171	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.06e-05	0.000171	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ENO1—esophageal cancer	2.06e-05	0.000171	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ABCB1—esophageal cancer	2.06e-05	0.000171	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PSME2—esophageal cancer	2.03e-05	0.000168	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PSME1—esophageal cancer	2.03e-05	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TYMP—esophageal cancer	2.02e-05	0.000168	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TYMP—esophageal cancer	2.01e-05	0.000167	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EGFR—esophageal cancer	2.01e-05	0.000166	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.99e-05	0.000165	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLCE1—esophageal cancer	1.98e-05	0.000164	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADH7—esophageal cancer	1.98e-05	0.000164	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.98e-05	0.000164	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC10A2—esophageal cancer	1.98e-05	0.000164	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CA1—esophageal cancer	1.98e-05	0.000164	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.97e-05	0.000163	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	1.97e-05	0.000163	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.97e-05	0.000163	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADH7—esophageal cancer	1.97e-05	0.000163	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP26A1—esophageal cancer	1.96e-05	0.000162	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—NOTCH1—esophageal cancer	1.95e-05	0.000162	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ENO1—esophageal cancer	1.95e-05	0.000161	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS1—esophageal cancer	1.95e-05	0.000161	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.94e-05	0.000161	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.92e-05	0.000159	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PSME2—esophageal cancer	1.92e-05	0.000159	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PSME1—esophageal cancer	1.92e-05	0.000159	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ALOX15—esophageal cancer	1.91e-05	0.000158	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.89e-05	0.000157	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	1.85e-05	0.000153	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TPI1—esophageal cancer	1.83e-05	0.000152	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.83e-05	0.000152	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TPI1—esophageal cancer	1.82e-05	0.000151	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTO1—esophageal cancer	1.82e-05	0.000151	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CA2—esophageal cancer	1.81e-05	0.00015	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TYMP—esophageal cancer	1.81e-05	0.00015	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.77e-05	0.000147	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—CREBBP—esophageal cancer	1.77e-05	0.000147	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.77e-05	0.000146	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.76e-05	0.000146	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.76e-05	0.000146	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP1B1—esophageal cancer	1.75e-05	0.000145	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ALDOB—esophageal cancer	1.75e-05	0.000145	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.74e-05	0.000144	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.72e-05	0.000143	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.71e-05	0.000142	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS2—esophageal cancer	1.7e-05	0.000141	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.69e-05	0.00014	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—HMOX1—esophageal cancer	1.69e-05	0.00014	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.68e-05	0.000139	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADH7—esophageal cancer	1.68e-05	0.000139	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GAPDH—esophageal cancer	1.68e-05	0.000139	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.67e-05	0.000139	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CRABP1—esophageal cancer	1.67e-05	0.000138	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMP—esophageal cancer	1.66e-05	0.000138	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.66e-05	0.000138	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.66e-05	0.000137	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP1B1—esophageal cancer	1.66e-05	0.000137	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMP—esophageal cancer	1.65e-05	0.000137	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.65e-05	0.000136	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.63e-05	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TPI1—esophageal cancer	1.63e-05	0.000135	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ABCB1—esophageal cancer	1.62e-05	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.62e-05	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.6e-05	0.000133	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNG7—esophageal cancer	1.59e-05	0.000132	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNG7—esophageal cancer	1.58e-05	0.000131	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.58e-05	0.000131	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.57e-05	0.00013	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.56e-05	0.000129	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.56e-05	0.000129	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.56e-05	0.000129	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—CREBBP—esophageal cancer	1.53e-05	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.51e-05	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.5e-05	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TPI1—esophageal cancer	1.5e-05	0.000125	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—HMOX1—esophageal cancer	1.5e-05	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.49e-05	0.000124	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.49e-05	0.000124	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.49e-05	0.000124	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.49e-05	0.000124	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TPI1—esophageal cancer	1.49e-05	0.000124	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ALDH2—esophageal cancer	1.48e-05	0.000123	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.47e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.47e-05	0.000122	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ABCB1—esophageal cancer	1.44e-05	0.00012	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.44e-05	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.43e-05	0.000118	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNG7—esophageal cancer	1.42e-05	0.000118	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.42e-05	0.000118	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.42e-05	0.000118	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTT1—esophageal cancer	1.41e-05	0.000117	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMP—esophageal cancer	1.41e-05	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.4e-05	0.000116	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.4e-05	0.000116	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP2A6—esophageal cancer	1.4e-05	0.000116	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.39e-05	0.000115	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.39e-05	0.000115	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CREBBP—esophageal cancer	1.38e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.38e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.37e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.37e-05	0.000114	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS3—esophageal cancer	1.37e-05	0.000113	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.36e-05	0.000113	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.36e-05	0.000113	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.33e-05	0.000111	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.33e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.33e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ENO1—esophageal cancer	1.33e-05	0.00011	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS1—esophageal cancer	1.32e-05	0.00011	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ENO1—esophageal cancer	1.32e-05	0.00011	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.32e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PSME2—esophageal cancer	1.31e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PSME1—esophageal cancer	1.31e-05	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNG7—esophageal cancer	1.31e-05	0.000108	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PSME2—esophageal cancer	1.3e-05	0.000108	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PSME1—esophageal cancer	1.3e-05	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNG7—esophageal cancer	1.3e-05	0.000107	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.27e-05	0.000106	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TPI1—esophageal cancer	1.27e-05	0.000106	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.27e-05	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.25e-05	0.000104	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.25e-05	0.000103	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NOS3—esophageal cancer	1.23e-05	0.000102	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.23e-05	0.000102	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.23e-05	0.000102	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.22e-05	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.21e-05	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.19e-05	9.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ENO1—esophageal cancer	1.19e-05	9.84e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.18e-05	9.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSME1—esophageal cancer	1.17e-05	9.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PSME2—esophageal cancer	1.17e-05	9.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.17e-05	9.66e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.16e-05	9.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.16e-05	9.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.15e-05	9.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.14e-05	9.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.14e-05	9.47e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.14e-05	9.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.14e-05	9.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.13e-05	9.38e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—esophageal cancer	1.13e-05	9.34e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1B1—esophageal cancer	1.12e-05	9.32e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNG7—esophageal cancer	1.11e-05	9.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ENO1—esophageal cancer	1.09e-05	9.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.09e-05	9.05e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.09e-05	9.04e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CREBBP—esophageal cancer	1.08e-05	8.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ENO1—esophageal cancer	1.08e-05	8.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.08e-05	8.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSME1—esophageal cancer	1.08e-05	8.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PSME2—esophageal cancer	1.08e-05	8.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSME1—esophageal cancer	1.07e-05	8.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PSME2—esophageal cancer	1.07e-05	8.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.06e-05	8.82e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP19A1—esophageal cancer	1.06e-05	8.77e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—esophageal cancer	1.05e-05	8.71e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—EP300—esophageal cancer	1.04e-05	8.62e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.04e-05	8.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.02e-05	8.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.01e-05	8.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—esophageal cancer	9.87e-06	8.19e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2A6—esophageal cancer	9.76e-06	8.09e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.72e-06	8.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—esophageal cancer	9.71e-06	8.05e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—esophageal cancer	9.7e-06	8.04e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—esophageal cancer	9.65e-06	8e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CREBBP—esophageal cancer	9.64e-06	7.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.52e-06	7.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP19A1—esophageal cancer	9.49e-06	7.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.47e-06	7.85e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—EP300—esophageal cancer	9.37e-06	7.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.32e-06	7.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—esophageal cancer	9.32e-06	7.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	9.29e-06	7.7e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—esophageal cancer	9.26e-06	7.68e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS1—esophageal cancer	9.25e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO1—esophageal cancer	9.25e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1B1—esophageal cancer	9.21e-06	7.63e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSME2—esophageal cancer	9.12e-06	7.56e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PSME1—esophageal cancer	9.12e-06	7.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CREBBP—esophageal cancer	9.11e-06	7.56e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—esophageal cancer	8.87e-06	7.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	8.73e-06	7.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—esophageal cancer	8.66e-06	7.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.66e-06	7.18e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—esophageal cancer	8.63e-06	7.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.5e-06	7.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—esophageal cancer	8.31e-06	6.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—esophageal cancer	8.16e-06	6.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—esophageal cancer	7.97e-06	6.61e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.96e-06	6.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.9e-06	6.55e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—esophageal cancer	7.89e-06	6.54e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1B1—esophageal cancer	7.87e-06	6.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.75e-06	6.42e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—esophageal cancer	7.69e-06	6.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—esophageal cancer	7.65e-06	6.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.58e-06	6.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—esophageal cancer	7.46e-06	6.19e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—esophageal cancer	7.44e-06	6.17e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP19A1—esophageal cancer	7.4e-06	6.13e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—EP300—esophageal cancer	7.38e-06	6.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.04e-06	5.84e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7e-06	5.81e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—esophageal cancer	6.93e-06	5.75e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—esophageal cancer	6.75e-06	5.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.62e-06	5.49e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—EP300—esophageal cancer	6.56e-06	5.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—esophageal cancer	6.48e-06	5.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.29e-06	5.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CREBBP—esophageal cancer	6.23e-06	5.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—EP300—esophageal cancer	6.21e-06	5.15e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CREBBP—esophageal cancer	6.19e-06	5.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.73e-06	4.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—esophageal cancer	5.57e-06	4.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CREBBP—esophageal cancer	5.56e-06	4.61e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—esophageal cancer	5.54e-06	4.59e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	5.46e-06	4.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.11e-06	4.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—esophageal cancer	5.1e-06	4.23e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—esophageal cancer	5.07e-06	4.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.07e-06	4.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—esophageal cancer	4.98e-06	4.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.9e-06	4.06e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—esophageal cancer	4.86e-06	4.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—esophageal cancer	4.59e-06	3.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—esophageal cancer	4.58e-06	3.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—esophageal cancer	4.55e-06	3.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—esophageal cancer	4.54e-06	3.76e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CREBBP—esophageal cancer	4.33e-06	3.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—EP300—esophageal cancer	4.24e-06	3.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—EP300—esophageal cancer	4.22e-06	3.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.19e-06	3.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.15e-06	3.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—esophageal cancer	3.88e-06	3.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—EP300—esophageal cancer	3.78e-06	3.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—esophageal cancer	3.55e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—EP300—esophageal cancer	3.48e-06	2.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—EP300—esophageal cancer	3.45e-06	2.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.14e-06	2.6e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—esophageal cancer	3.12e-06	2.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—EP300—esophageal cancer	2.95e-06	2.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.8e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.58e-06	2.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.55e-06	2.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.18e-06	1.81e-05	CbGpPWpGaD
